Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mersil Neuro
- Development stage
- Unknown
- Lead developer
- Grand Medical Group
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Mersil Neuro is an oral dietary supplement developed by Grand Medical Group to support cardiovascular and neurological health, manage stress, and prevent magnesium and B-vitamin deficiencies. It is formulated as a capsule containing a combination of magnesium citrate, thiamine mononitrate (vitamin B1), riboflavin (vitamin B2), pyridoxine hydrochloride (vitamin B6), cyanocobalamin (vitamin B12), folic acid (vitamin B9), and the prebiotic fiber inulin. Magnesium regulates neuronal excitability and neuromuscular transmission, while the B-complex vitamins act as essential coenzymes in metabolic pathways, neurotransmitter synthesis, and red blood cell production. Inulin enhances the absorption of these micronutrients and supports digestive health.
- Brand names
- Mersil Neuro
- Other names
- Mercil Neuro
Beyond the preview
Go deeper on Mersil Neuro.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mersil Neuro.